Clinical trials
Phase 4 Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
91 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 7 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 7 |
| 2018 | 5 |
| 2019 | 10 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 7 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 46 |
| Unknown status | 16 |
| Recruiting | 12 |
| Terminated | 9 |
| Not yet recruiting | 4 |
| Active, not recruiting | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 9 |
| Hoffmann-La Roche | 6 |
| Betta Pharmaceuticals Co., Ltd. | 4 |
| Radboud University Medical Center | 4 |
| Boehringer Ingelheim | 3 |
| Eli Lilly and Company | 3 |
| Novartis Pharmaceuticals | 3 |
| Pfizer | 3 |
| Simcere Pharmaceutical Co., Ltd | 3 |
| Peking University First Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 91 |
| Lung Neoplasms | 18 |
| Carcinoma | 4 |
| Carcinoma, Renal Cell | 4 |
| Melanoma | 4 |
| Stomach Neoplasms | 4 |
| Carcinoma, Hepatocellular | 3 |
| Esophageal Neoplasms | 3 |
| Kidney Neoplasms | 3 |
| Mesothelioma | 3 |
Trials
Showing 51 to 75 of 91. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.